Biopharmaceutical manufacturing capacity has moved through three discrete chapters in its 25-year history. Could the next chapter herald formal manufacturing-capacity sharing among companies?
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Kinetics of substrate utilization and bacterial growth of crude oil degraded by Pseudomonas aeruginosa
Journal of Environmental Health Science and Engineering Open Access 24 September 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Frost & Sullivan . Strategic Analysis of Downstream Processing in Biopharmaceutical Production (Frost & Sullivan, New York, 2004).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kamarck, M. Building biomanufacturing capacity—the chapter and verse. Nat Biotechnol 24, 503–505 (2006). https://doi.org/10.1038/nbt0506-503
Issue Date:
DOI: https://doi.org/10.1038/nbt0506-503
This article is cited by
-
Developing therapeutic monoclonal antibodies at pandemic pace
Nature Biotechnology (2020)
-
Kinetics of substrate utilization and bacterial growth of crude oil degraded by Pseudomonas aeruginosa
Journal of Environmental Health Science and Engineering (2015)